4
Changes in Ownership
Neurogene Inc. Filed Acc 0001209191-22-044432
Options or other derivatives
- President and CEO acquired 350,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DRACHMAN JONATHAN G · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-08-02 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +350,000 | 350,000 | D |
Loading xslF345X03/doc4.xml…